optimal screening method for colorectal pre-cancerous lesion and its correlation with background mucosal abnormal DNA methylation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300077409

Enrollment

Unknown

Registered

2023-11-07

Start date

2023-11-13

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

precancerous lesions of colorectal cancer

Interventions

case group:NA

control group:NA

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: subjects schedule for initial colonoscopy screening and without anti-platelet medicine use history in the past 5 days.

Exclusion criteria

Exclusion criteria: patients with poor bowel preparation (Boston Bowel Preparation Scale, BBPS score < 6 points or any segmental score < 2 points); colorectal surgery history; IBD; FAP; colonoscope withdrawal time less than 6 min; and patients who refused to participate in the study.

Design outcomes

Primary

Measure	Time frame
spearman correlation coefficient;	—

Countries

China

Contacts

Public ContactChen Xing

The First Hospital of Shanxi Medical University

chen0419xing@163.com+86 183 2460 0502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026